Company Profile

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE415.10-8.2 (-1.94 % )
PREV CLOSE (Rs.) 423.30
OPEN PRICE (Rs.) 425.00
BID PRICE (QTY) 415.10 (332 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 394767
TODAY'S LOW / HIGH (Rs.)414.00 428.00
52 WK LOW / HIGH (Rs.)375.4 678.8
NSE414.65 -8.25 (-1.95 % )
PREV CLOSE(Rs.) 422.90
OPEN PRICE (Rs.) 424.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 414.65 (7762 )
VOLUME 6210412
TODAY'S LOW / HIGH(Rs.) 413.30 428.00
52 WK LOW / HIGH (Rs.)370.2 679.3

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1638.68
Dividend Yield(%) 0.48
TTM EPS (Rs.) -2.12
P/E Ratio 0.00
Book Value (Rs.) 77.46
Face Value (Rs.) 1
MCap (Rs. in Mn) 995963.95
Price/Earning (TTM) -269179.44
Price/Sales (TTM) 10.88
Price/Book (MRQ) 5.36
PAT Margin (%) -6.22
ROCE (%) -0.49
Incorporation Year : 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
13Feb02-13-2019$Sun Pharma reports around 4-fold jump in Q3 consolidated net profit Sun Pharma reports around 4-

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2018.

The company has reported a net loss of Rs 38.68 crore for the quarter under review against net profit of Rs 320.65 crore for the same quarter in the previous year. Total income of the company decreased by 6.26% at Rs 2289.02 crore for Q3FY19 as compared Rs 2441.90 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported around 4-fold jump in its net profit at Rs 1,241.85 crore for the quarter under review as compared to Rs 321.57 crore for the same quarter in the previous year. Total income of the company increased by 16.97% at Rs 7,933.25 crore for Q3FY19 as compared Rs 6,782.42 crore for the corresponding quarter previous year.

Sun Pharmaceutical Industries has reported results for third qu..
13Feb02-13-2019$Sun Pharma shines on reporting around 4-fold jump in Q3 consolidated net profit Sun Pharma shines on reporti

Sun Pharmaceutical Industries is currently trading at Rs. 448.75, up by 12.00 points or 2.75% from its previous closing of Rs. 436.75 on the BSE.

The scrip opened at Rs. 451.50 and has touched a high and low of Rs. 454.40 and Rs. 445.85 respectively. So far 496017 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.

Last one week high and low of the scrip stood at Rs. 454.40 and Rs. 421.00 respectively. The current market cap of the company is Rs. 104790.95 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.

Sun Pharmaceutical Industries has reported a net loss of Rs 38.68 crore for the quarter ended December 31, 2018 against net profit of Rs 320.65 crore for the same quarter in the previous year. Total income of the company decreased by 6.26% at Rs 2289.02 crore for Q3FY19 as compared Rs 2441.90 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported around 4-fold jump in its net profit at Rs 1,241.85 crore for the quarter ended December 31, 2018 as compared to Rs 321.57 crore for the same quarter in the previous year. Total income of the company increased by 16.97% at Rs 7,933.25 crore for Q3FY19 as compared Rs 6,782.42 crore for the corresponding quarter previous year.

Sun Pharmaceutical Industries is currently trading at Rs. 448.7..
04Feb02-04-2019$Sun Pharmaceutical Industries informs about disclosure Sun Pharmaceutical Industrie

Sun Pharmaceutical Industries has informed that the exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia.

The above information is a part of company’s filings submitted to BSE.

Sun Pharmaceutical Industries has informed that the exchange ha..
22Jan01-22-2019$Sun Pharma to replace domestic formulations distributor with its own subsidiary Sun Pharma to replace domest

Sun Pharmaceutical Industries is going to replace its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower complaint filed against the company. This change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharmaceutical Industries is going to replace its domestic..
22Jan01-22-2019$Sun Pharma trades higher on the BSE Sun Pharma trades higher on

Sun Pharmaceutical Industries is currently trading at Rs. 417.15, up by 18.80 points or 4.72% from its previous closing of Rs. 398.35 on the BSE.

The scrip opened at Rs. 408.60 and has touched a high and low of Rs. 421.15 and Rs. 408.60 respectively. So far 1447242 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.

Last one week high and low of the scrip stood at Rs. 457.15 and Rs. 375.40 respectively. The current market cap of the company is Rs. 100459.87 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.

Sun Pharmaceutical Industries is going to replace its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower complaint filed against the company. This change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharmaceutical Industries is currently trading at Rs. 417.1..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit-386.8-4945.9
Gross Profit -650.7 -5199.8
Operating Profit 2023.712510.6
Net Sales 22612.679476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Hester Biosciences (BSE)
 1408.00 (2.33%)
M.Cap ( in Cr)
1197.77
Ipca Laboratories (BSE)
 805.00 (3.87%)
M.Cap ( in Cr)
10171.34
Alkem Laboratories (BSE)
 1831.35 (1.56%)
M.Cap ( in Cr)
21896.54
Dr. Reddys Lab (BSE)
 2570.00 (0.51%)
M.Cap ( in Cr)
42677.64
Piramal Enterprises (BSE)
 2169.25 (0.40%)
M.Cap ( in Cr)
39922.92
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.69 %
FI/BANKS/INSURANCE 7.8 %
PROMOTERS 54.38 %
NON-INSTITUTION 13.09 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested